SCHEMBL26961832

SCHEMBL26961832

CC(C)(C)OC(=O)N[C@H]1CS(=O)(=O)c2cc(F)c(-c3nnc(C45CC(CN(C(=O)OC(C)(C)C)C4)C5)o3)cc2N(Cc2ccc(Cl)cc2)C1=O

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ NPY1R P25929 1/20 0.31
▸ OXTR P30559 1/20 0.30
▸ AVPR1A P37288 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26961877 0.89 BDKRB1 (0.33) NPY1R
SCHEMBL30767621 0.88 ENPP2 (0.30) NPY1R
SCHEMBL26961683 0.88 POLB (0.30) —
SCHEMBL29796869 0.88 POLB (0.30) —
SCHEMBL26961899 0.85 POLB (0.33) NPY1R
SCHEMBL26962215 0.85 NPY1R (0.33) NPY1R
SCHEMBL29796225 0.85 — —
SCHEMBL26963091 0.85 — —
SCHEMBL26961707 0.84 CCR1 (0.33) NPY1R
SCHEMBL26961979 0.84 NPY1R (0.31) NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
Send feedback